147 related articles for article (PubMed ID: 27057984)
1. Impact of common β1-adrenergic receptor polymorphisms on the interaction with agonistic autoantibodies in dilated cardiomyopathy.
Bornholz B; Hanzen B; Reinke Y; Felix SB; Boege F
Int J Cardiol; 2016 Jul; 214():83-5. PubMed ID: 27057984
[No Abstract] [Full Text] [Related]
2. Detection of DCM-associated β1-adrenergic receptor autoantibodies requires functional readouts or native human β1-receptors as targets.
Bornholz B; Hanzen B; Reinke Y; Felix SB; Jahns R; Schimke I; Wallukat G; Boege F
Int J Cardiol; 2016 Jan; 202():728-30. PubMed ID: 26461921
[No Abstract] [Full Text] [Related]
3. Are autoantibodies against the beta1-adrenergic receptor markers for dilated cardiomyopathy?
Arndt-Marić R; Nägele H; Schewe G; Kromminga A
Clin Lab; 2010; 56(11-12):519-26. PubMed ID: 21141435
[TBL] [Abstract][Full Text] [Related]
4. Agonistic anti-beta1-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the beta1-adrenergic receptor expression in neonatal rat cardiomyocytes.
Podlowski S; Luther HP; Morwinski R; Müller J; Wallukat G
Circulation; 1998 Dec; 98(22):2470-6. PubMed ID: 9832494
[TBL] [Abstract][Full Text] [Related]
5. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
Haberland A; Wallukat G; Dahmen C; Kage A; Schimke I
Circ Res; 2011 Oct; 109(9):986-92. PubMed ID: 21868696
[TBL] [Abstract][Full Text] [Related]
6. The beta-adrenergic receptors.
Wallukat G
Herz; 2002 Nov; 27(7):683-90. PubMed ID: 12439640
[TBL] [Abstract][Full Text] [Related]
7. Anti-beta1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells.
Tutor AS; Penela P; Mayor F
Cardiovasc Res; 2007 Oct; 76(1):51-60. PubMed ID: 17628514
[TBL] [Abstract][Full Text] [Related]
8. A standardised FACS assay based on native, receptor transfected cells for the clinical diagnosis and monitoring of β1-adrenergic receptor autoantibodies in human heart disease.
Bornholz B; Benninghaus T; Reinke Y; Felix SB; Roggenbuck D; Jahns-Boivin V; Jahns R; Boege F
Clin Chem Lab Med; 2016 Apr; 54(4):683-91. PubMed ID: 26408610
[TBL] [Abstract][Full Text] [Related]
9. Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy.
Wallukat G; Müller J; Hetzer R
N Engl J Med; 2002 Nov; 347(22):1806. PubMed ID: 12456865
[No Abstract] [Full Text] [Related]
10. [The role of anti-beta1-adrenergic receptor autoantibodies in development of heart failure].
Tonevitskiĭ AG; Tabak'an EA
Ross Fiziol Zh Im I M Sechenova; 2006 Mar; 92(3):330-41. PubMed ID: 16739643
[TBL] [Abstract][Full Text] [Related]
11. Beta1-adrenergic receptor gene polymorphisms in Mexican patients with idiopathic dilated cardiomyopathy.
Fragoso JM; Rodríguez-Pérez JM; González J; Cruz D; Pérez-Méndez O; de Jesus García J; de la Peña A; Arce M; Reyes PA; Vargas-Alarcón G
Exp Mol Pathol; 2006 Jun; 80(3):279-82. PubMed ID: 16487965
[TBL] [Abstract][Full Text] [Related]
12. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
[TBL] [Abstract][Full Text] [Related]
13. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy.
Dandel M; Wallukat G; Potapov E; Hetzer R
Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755
[TBL] [Abstract][Full Text] [Related]
14. Plasma exchange treatment to reduce anti-beta1-adrenergic receptor antibody in a patient with dilated cardiomyopathy.
Gesinde MO; Tan LB; Gooi HC
J Clin Apher; 2007; 22(4):241-2. PubMed ID: 17385717
[No Abstract] [Full Text] [Related]
15. Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas' heart disease.
Levin MJ; Hoebeke J
Autoimmunity; 2008 Sep; 41(6):429-33. PubMed ID: 18781468
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
[TBL] [Abstract][Full Text] [Related]
17. Detection of anti-β1-AR autoantibodies in heart failure by a cell-based competition ELISA.
Holthoff HP; Zeibig S; Jahns-Boivin V; Bauer J; Lohse MJ; Kääb S; Clauss S; Jahns R; Schlipp A; Münch G; Ungerer M
Circ Res; 2012 Aug; 111(6):675-84. PubMed ID: 22811559
[TBL] [Abstract][Full Text] [Related]
18. [The immune-enzyme analysis based on chimeric molecule and oligopeptide fragmentations to detect autoantibodies to beta-adrenergic receptor in patients with dilation cardiomyopathy].
Afanas'eva OI; Klesareva EA; Efremov EE; Sidorova MV; Bespalova ZhD; Levashov PA; Ezhov MV; Adamova IIu; Pokrovskiĭ SN
Klin Lab Diagn; 2013 Apr; (4):24-7. PubMed ID: 23984550
[TBL] [Abstract][Full Text] [Related]
19. Doberman pinschers present autoimmunity associated with functional autoantibodies: A model to study the autoimmune background of human dilated cardiomyopathy.
Wess G; Wallukat G; Fritscher A; Becker NP; Wenzel K; Müller J; Schimke I
PLoS One; 2019; 14(7):e0214263. PubMed ID: 31276517
[TBL] [Abstract][Full Text] [Related]
20. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
